Patients with obstructive sleep apnea and daytime sleepiness had a 66% higher risk of atherosclerosis than those with neither condition, a Brazilian analysis found.
4 Jul 2023
Two industry-supported studies of continuous glucose monitoring (CGM) found encouraging results in patients with type 2 diabetes, leading editorialists to call for broadened access to the technology in this population, particularly in primary care.
8 Jun 2021
Risk may be lower with long-acting insulin analogs versus neutral protamine Hagedorn (NPH) insulin.
9 Mar 2021
In an analysis of the Nurses' Health and Health Professionals studies, regular users of proton-pump inhibitors (PPIs) had a 24% higher risk of diabetes than nonusers, with longer duration of use associated with greater risk.
6 Oct 2020
Participants in the Norfolk Diabetes Prevention Study who underwent multiple educational group sessions that included 50-minute sessions of supervised physical activity had significantly lower odds of type 2 diabetes during a mean follow-up of two years compared to those who received usual care.
10 Nov 2020
Unemployment, lower family income, food insecurity, not owning a home, and not being married or living with a partner were significantly associated with cardiovascular disease (CVD) mortality independently of established behavioral and metabolic risk factors.
15 Aug 2023
Researchers used data from the National Health and Nutrition Examination Survey to determine the body mass index and age thresholds for diabetes screening in major racial/ethnic minority populations.
10 May 2022
The World Health Organization (WHO) cited a lack of evidence suggesting that short-term use of nonsugar sweeteners affected body weight or other measures of adiposity, as well as possible long-term undesirable effects on noncommunicable diseases and death.
23 May 2023
Once-weekly insulin had similar effects to daily insulin in type 2 diabetes, industry-funded trial finds
HbA1c levels improved by more than a point in insulin-naive patients with inadequately controlled type 2 diabetes who were randomized to a weekly 70-U dose of an investigational insulin.
29 Sep 2020
Analysis of a randomized trial of aspirin in healthy older patients found significantly increased risk of anemia, faster decline in hemoglobin concentrations, and greater decline in ferritin levels with aspirin versus placebo.
20 Jun 2023